Delivery science · Part 1

Why most of your supplement never makes it in.

You can take the right nutrient at the right dose and still get almost nothing from it. Here's what's actually going on — and how liposomal encapsulation changes the math.

Scroll to follow a dose

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This page is educational, not medical advice — talk to a licensed clinician about your own situation.

The real bottleneck

The problem isn't the nutrient. It's the delivery.

You've done the homework. You picked a compound with real research behind it, checked the dose, maybe even spent a little more for a clean label. And it's reasonable to assume that what's on the label is what reaches your bloodstream.

Often, it isn't. Many of the most useful nutrients — curcumin is the classic example — are poorly absorbed on their own. Curcumin is fat-soluble, breaks down in the gut, and gets cleared by the liver quickly. The result is that only a small fraction of a standard dose ends up circulating where your body can use it.

This is the gap delivery science tries to close. The honest answer is that the nutrient was never the bottleneck — getting it past digestion was. That's the problem liposomal encapsulation is built to solve.

“A nutrient you can't absorb is a nutrient you didn't really take. The absorption is the point.”

What it is

Anatomy of a liposome.

A liposome is a microscopic bubble — a sphere made of the same kind of fat molecules that build your own cell membranes. That structure is the whole trick: it's familiar to your body, and it can carry a payload tucked safely inside.

  • 01Aqueous core
  • 02Phospholipid bilayer
  • 03The payload
How it works

The trip a nutrient has to survive

  1. Swallowed

    Every dose starts whole.

    Two doses of the same nutrient go in. One is unprotected; one is wrapped in a phospholipid shell.

  2. The stomach

  3. The small intestine

  4. Cell membranes

  5. The bloodstream

Standard form

24/24

Liposomal

24/24

Illustrative — not a clinical result. Gains vary by nutrient and formulation.

What the numbers say

The absorption gap, drawn out.

Bioavailability is the share of a dose that actually reaches circulation. For standard curcumin it's strikingly low — often cited in the low single digits of a percent. Encapsulation is designed to raise that curve.

Liposomal Standard
0h1h2h3h4h6h8h12h

What matters: the exact multiplier depends on the formulation, the dose, and the study — and human outcome trials (does more absorption translate to how you feel?) are still genuinely preliminary. The chart below is illustrative of the shape of the difference, not a specific clinical result.

What the research shows

The honest state of the evidence.

Here's what's well-established, and where things are still developing. We've linked every source so you can read it yourself.

The core problem

Standard curcumin is poorly absorbed

This is the settled part. Reviews of curcumin pharmacokinetics consistently describe low oral bioavailability — driven by poor water solubility, rapid breakdown, and fast clearance. It's the reason delivery technology exists for this ingredient at all.

The mechanism

Phospholipid delivery improves absorption

Across formulation reviews and pharmacokinetic studies, wrapping curcumin in phospholipids or liposomes raises how much reaches the bloodstream versus standard curcumin. The size of the gain varies by formulation, but the direction is consistent.

Human pharmacokinetics

Measured in people, not just lab models

A randomized human study of a phospholipid-decorated liposomal curcumin reported a large jump in plasma curcumin and a longer half-life versus standard curcumin. Findings like this are promising — and a reminder that results are formulation-specific.

The biology

Why curcumin is studied in the first place

Curcumin is researched for its role in the body's normal inflammatory and antioxidant pathways — for example, its interaction with the NF-κB signaling pathway. This is mechanism research; it is not a claim that any supplement treats a condition.

What's still open

Absorption up. Outcomes: earlier-stage.

Better absorption is well-supported. Whether that reliably changes how people feel — and by how much — is where the evidence is thinner and ongoing. We think it's worth saying plainly rather than papering over.

Our approach

What this means for how we build.

Practically, this is why Manna leads with delivery. We formulate around getting the active where it needs to go — using a phospholipid liposomal system rather than relying on absorption enhancers like black pepper, which many people find hard on the stomach.

We're not here to promise an outcome or recommend a dose — that's a conversation for your clinician. We're here to make sure the delivery side isn't the reason a good ingredient underperforms.

See it in Liposomal Curcumin+
Next in the series

Curcumin & Curcuminoids

Turmeric's most-studied compounds, what 95% standardized curcuminoids really means, and why pairing them with liposomal delivery is the whole idea.

Read the curcumin explainer

References

  1. 01Anand et al., Molecular Pharmaceutics, 2007Bioavailability of curcumin: problems and promises — a foundational review of why oral curcumin is poorly absorbed.
  2. 02Frontiers in Pharmacology, 2025Recent review of curcumin's pharmacology, formulations, and clinical research progress — including liposomal delivery.
  3. 03Discover Nano (Springer), 2025Contemporary review of curcumin nanocarriers, including liposomes, and how lipid composition affects performance.
  4. 04ACS Omega, 2023 (PMC10372937)Randomized human pharmacokinetic study of a phospholipid-decorated liposomal curcumin reporting large gains in plasma curcumin.
  5. 05Curcumin bioavailability review (PMC10180326)Review of strategies — including liposomal delivery — used to improve curcumin absorption.
  6. 06Aggarwal & Sung, Trends in Pharmacological Sciences, 2008Curcumin's interaction with the NF-κB signaling pathway — mechanism research on inflammatory signaling.
  7. 07Curcumin antioxidant review (PMC5664031)Review of curcumin's antioxidant and free-radical-scavenging activity.
  8. 08Curcumin & inflammatory pathways (PMC10111629)Review of curcumin's role in normal inflammatory pathways and the gaps that remain in clinical evidence.
  9. 09Liposomal/phospholipid curcumin formulation study, 2018Formulation and pharmacokinetic work on phospholipid-based curcumin delivery.
  10. 10Lipid-based delivery review (PMC7357038)Review of lipid-based and liposomal delivery systems for poorly absorbed nutrients.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This page is educational, not medical advice — talk to a licensed clinician about your own situation.